Redmile Group, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 63 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$2,101,000
+0.8%
323,265
-2.7%
0.06%
-40.8%
Q3 2017$2,084,000
+2.3%
332,3100.0%0.10%
-16.9%
Q2 2017$2,037,000
+98.0%
332,310
+137.0%
0.12%
+85.1%
Q1 2017$1,029,000
+1236.4%
140,243
+281.7%
0.07%
+857.1%
Q4 2016$77,000
-86.4%
36,743
-80.4%
0.01%
-84.4%
Q3 2016$565,000
+615.2%
187,610
+560.4%
0.04%
+462.5%
Q2 2016$79,000
+36.2%
28,410
+44.1%
0.01%
+33.3%
Q1 2016$58,000
+41.5%
19,710
+18.7%
0.01%
+100.0%
Q4 2015$41,00016,6100.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders